Spots Global Cancer Trial Database for locally advanced basal cell carcinoma
Every month we try and update this database with for locally advanced basal cell carcinoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Treatment Duration Increment and Pharmacodynamic Study of CX-4945 in Patients With Basal Cell Carcinoma (BCC) | NCT03897036 | Carcinoma, Basa... | CX-4945 | 18 Years - | Senhwa Biosciences, Inc. | |
| Oral Hedgehog Inhibitors in the Treatment of Basal Cell Carcinoma in the Netherlands: a Prospective Registration Study | NCT05463757 | Basal Cell Carc... Locally Advance... Metastatic Basa... Gorlin Syndrome Basal Cell Nevu... Carcinoma, Basa... Carcinoma Basal Cell Tumo... Skin Cancer Neoplasm of Ski... Neoplasms, Basa... | Vismodegib Sonidegib | - | Maastricht University Medical Center | |
| Post-authorization Safety Study on the Long Term Safety of Sonidegib in Patients With Locally Advanced Cell Carcinoma | NCT04066504 | Basal Cell Carc... | sonidegib | 18 Years - | Sun Pharmaceutical Industries Limited | |
| Tailored Sonidegib Schedule After Complete Response in BCC | NCT04806646 | Locally Advance... | Sonidegib | 18 Years - | Gruppo Oncologico del Nord-Ovest | |
| Post-authorization Safety Study on the Long Term Safety of Sonidegib in Patients With Locally Advanced Cell Carcinoma | NCT04066504 | Basal Cell Carc... | sonidegib | 18 Years - | Sun Pharmaceutical Industries Limited | |
| Open-label Trial of SUBA™-Itraconazole (SUBA-Cap) in Subjects With Basal Cell Carcinoma Nevus Syndrome (BCCNS) | NCT02354261 | Basal Cell Carc... | SUBA-Itraconazo... | 18 Years - | HedgePath Pharmaceuticals, Inc. | |
| Treatment Duration Increment and Pharmacodynamic Study of CX-4945 in Patients With Basal Cell Carcinoma (BCC) | NCT03897036 | Carcinoma, Basa... | CX-4945 | 18 Years - | Senhwa Biosciences, Inc. | |
| A Phase II Study of Efficacy and Safety in Patients With Locally Advanced or Metastatic Basal Cell Carcinoma | NCT01327053 | Basal Cell Carc... | LDE225 | 18 Years - | Novartis | |
| Post-authorization Safety Study on the Long Term Safety of Sonidegib in Patients With Locally Advanced Cell Carcinoma | NCT04066504 | Basal Cell Carc... | sonidegib | 18 Years - | Sun Pharmaceutical Industries Limited | |
| Phase II Study of Radiation Therapy and Vismodegib for Advanced Head/Neck Basal Cell Carcinoma | NCT01835626 | Locally Advance... Skin Cancer Cutaneous Malig... | Vismodegib Radiation thera... | 18 Years - | University of California, San Francisco | |
| Tailored Sonidegib Schedule After Complete Response in BCC | NCT04806646 | Locally Advance... | Sonidegib | 18 Years - | Gruppo Oncologico del Nord-Ovest | |
| Radiotherapy by Sonic Hedgehog Pathway Inhibitors in Basal Cell Carcinoma | NCT05561634 | Basal Cell Carc... Radiotherapy; C... | Radiotherapy Observation Vismodegib | 18 Years - | University Hospital, Lille | |
| Phase II Study of Radiation Therapy and Vismodegib for Advanced Head/Neck Basal Cell Carcinoma | NCT01835626 | Locally Advance... Skin Cancer Cutaneous Malig... | Vismodegib Radiation thera... | 18 Years - | University of California, San Francisco |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
